Submissions
GlyTouCan
Glycan Structure Repository
GlyComb
Glycoconjugate Repository
GlycoPOST
Glycomics MS raw data Repository
UniCarb-DR
Glycomics MS Repository for glycan annotations from GlycoWorkbench
LM-GlycoRepo
Repository for lectin-assisted multimodality data
All Resources
Genes / Proteins / Lipids Glycans / Glycoconjugates Glycomes Pathways / Interactions / Diseases / Organisms
metabolic dysfunction-associated steatotic liver disease
Summary
- Synonym
-
- MAFLD
- MASLD
- NAFLD
- metabolic dysfunction-associated fatty liver disease
- metabolic dysfunction-related steatotic liver disease
- metabolic-associated fatty liver disease
- non-alcoholic fatty liver disease
- nonalcoholic fatty liver disease
- Definition
- A steatotic liver disease characterized by at least one of five cardiometabolic risk factors (adjusted for age, sex and ethnicity), alcohol consumption below 140g/week (female) or 210g/week (male), and no other discernible cause. The five cardiometabolic risk factors are: (1) Body mass index ≥ 25 kg/m2 (adult), 23 kg/m2 (adult Asian), or 85th percentile (pediatric); waist circumference > 94 cm (adult male), 80 cm (adult female), or 95th percentile (pediatric); or ethnicity adjusted equivalents. (2) Fasting serum glucose ≥ 5.6 mmol/L, 2-hr post-load glucose levels ≥ 7.8 mmol/L, glycated hemoglobin (HbA1c) ≥ 5.7% (39 mmol/L), type 2 diabetes, treatment for type 2 diabetes, previously diagnosed or treated type 2 diabetes (pediatric only), or serum glucose ≥ 11.1 mmol/L (pediatric only). (3) Blood pressure ≥ lower of 130/85 mmHg or 95th percentile (age < 13 years), or 130/85 mmHg (age ≥ 13 years); or specific hypertensive drug treatment. (4) Plasma triglycerides ≥ 1.15 mmol/L (age < 10 years) or 1.70 mmol/L (age ≥ 10 years); or lipid lowering treatment. (5) Plasma high-density lipoprotein cholesterol ≤ 1.0 mmol/L (adult male, pediatric) or 1.3 mmol/L (adult female); or lipid lowering treatment.
- Super Class
- steatotic liver disease
External Links
Related Genes
| Gene ID | Gene Symbol | Description | Source |
|---|---|---|---|
| 217 | ALDH2 | aldehyde dehydrogenase 2 family member | |
| 348 | APOE | apolipoprotein E | |
| 498 | ATP5F1A | ATP synthase F1 subunit alpha | |
| 563 | AZGP1 | alpha-2-glycoprotein 1, zinc-binding | |
| 1244 | ABCC2 | ATP binding cassette subfamily C member 2 | |
| 1277 | COL1A1 | collagen type I alpha 1 chain | |
| 1571 | CYP2E1 | cytochrome P450 family 2 subfamily E member 1 | |
| 2146 | EZH2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | |
| 2194 | FASN | fatty acid synthase | |
| 2308 | FOXO1 | forkhead box O1 |
| Gene ID | Gene Symbol | Description | Source |
|---|---|---|---|
| 11989 | Slc7a3 | solute carrier family 7 (cationic amino acid transporter, y+ system), member 3 | |
| 12007 | Azgp1 | alpha-2-glycoprotein 1, zinc | |
| 12780 | Abcc2 | ATP-binding cassette, sub-family member 2 | |
| 12842 | Col1a1 | collagen, type I, alpha 1 | |
| 14056 | Ezh2 | enhancer of zeste 2 polycomb repressive complex 2 subunit | |
| 14104 | Fasn | fatty acid synthase | |
| 14380 | G6pd2 | glucose-6-phosphate dehydrogenase 2 | |
| 14381 | G6pdx | glucose-6-phosphate dehydrogenase X-linked | |
| 14782 | Gsr | glutathione reductase | |
| 15216 | Hfe | homeostatic iron regulator |
| Gene ID | Gene Symbol | Description | Source |
|---|---|---|---|
| 29260 | Tlr4 | toll-like receptor 4 | |
| 29393 | Col1a1 | collagen type I alpha 1 chain | |
| 29485 | Slc7a3 | solute carrier family 7 member 3 | |
| 29539 | Aldh2 | aldehyde dehydrogenase 2 family member | |
| 50671 | Fasn | fatty acid synthase | |
| 54315 | Ucp2 | uncoupling protein 2 | |
| 60582 | Il1rn | interleukin 1 receptor antagonist | |
| 64678 | Tfrc | transferrin receptor | |
| 65262 | Atp5f1a | ATP synthase F1 subunit alpha | |
| 81822 | Actb | actin, beta |
| Gene ID | Gene Symbol | Description | Source |
|---|---|---|---|
| 31480 | Sirt4 | Sirtuin 4 | |
| 32974 | Zw | Zwischenferment | |
| 35362 | Mtp | Microsomal triacylglycerol transfer protein | |
| 36428 | Mdr49 | Multi drug resistance 49 | |
| 38726 | Mdr65 | Multi drug resistance 65 | |
| 41549 | Octbeta2R | Octopamine beta2 receptor | |
| 42549 | InR | Insulin-like receptor | |
| 42620 | PyK | Pyruvate kinase | |
| 42652 | Octbeta1R | Octopamine beta1 receptor | |
| 42803 | Hmgcr | HMG Coenzyme A reductase |
| Gene ID | Gene Symbol | Description | Source | Organism |
|---|---|---|---|---|
| 395003 | dgat2 | diacylglycerol O-acyltransferase 2 | Xenopus tropicalis (tropical clawed frog) | |
| 398800 | dgat2.L | diacylglycerol O-acyltransferase 2 L homeolog | Xenopus laevis (African clawed frog) | |
| 399170 | akt1.S | AKT serine/threonine kinase 1 S homeolog | Xenopus laevis (African clawed frog) | |
| 448598 | pon2 | paraoxonase 2 | Xenopus tropicalis (tropical clawed frog) |
| Gene ID | Gene Symbol | Description | Source |
|---|---|---|---|
| 171999 | poml-2 | Arylesterase | |
| 175410 | daf-2 | Insulin-like receptor subunit beta;Protein kinase domain-containing protein;receptor protein-tyrosine kinase | |
| 176852 | dsc-4 | Microsomal triglyceride transfer protein homolog | |
| 177343 | skn-1 | BZIP domain-containing protein;Protein skinhead-1 | |
| 178046 | gspd-1 | Glucose-6-phosphate 1-dehydrogenase | |
| 178215 | pgp-1 | Multidrug resistance protein pgp-1 | |
| 178672 | srp-3 | Serpin domain-containing protein | |
| 180289 | mrp-7 | Multidrug resistance protein mrp-7 | |
| 180408 | mrp-2 | Multidrug resistance-associated protein 1 | |
| 180409 | mrp-1 | Multidrug resistance-associated protein 1 |
| Gene ID | Gene Symbol | Description | Source |
|---|---|---|---|
| 851171 | HMG2 | hydroxymethylglutaryl-CoA reductase (NADPH) HMG2 | |
| 851193 | CDC19 | pyruvate kinase CDC19 | |
| 852803 | HNM1 | Hnm1p | |
| 853590 | VPS70 | putative zinc metalloprotease | |
| 853671 | STE6 | ATP-binding cassette a-factor transporter STE6 | |
| 854080 | YOL075C | uncharacterized protein | |
| 854419 | DGA1 | diacylglycerol O-acyltransferase | |
| 854430 | TRE2 | putative zinc metalloprotease | |
| 854529 | PYK2 | pyruvate kinase PYK2 | |
| 854900 | HMG1 | hydroxymethylglutaryl-CoA reductase (NADPH) HMG1 |
